Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 93: 1669-1675, 2002. First published July 12, 2002; doi:10.1152/japplphysiol.00145.2002
8750-7587/02 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
93/5/1669    most recent
00145.2002v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosendal, L.
Right arrow Articles by Kjær, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosendal, L.
Right arrow Articles by Kjær, M.
Vol. 93, Issue 5, 1669-1675, November 2002

Physical capacity influences the response of insulin-like growth factor and its binding proteins to training

Lars Rosendal1,2, Henning Langberg1, Allan Flyvbjerg3, Jan Frystyk3, Hans Ørskov3, and Michael Kjær1

1 Sports Medicine Research Unit and Copenhagen Muscle Research Centre, Bispebjerg Hospital, DK-2400 Copenhagen; 2 National Institute of Occupational Health, DK-2100 Copenhagen; and 3 Medical Research Laboratories, Aarhus University Hospital, DK-8000 Aarhus, Denmark


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The influence of initial training status on the response of circulating insulin-like growth factor (IGF) and its binding proteins (IGFBP) to prolonged physical training was studied in young men. It was hypothesized that highly standardized training would result in more extensive changes in the circulating IGF system in untrained subjects because of lower fitness level. Seven untrained (UT) and 12 well-trained (WT) individuals performed 11 wk of intense physical training (2-4 h daily). Fasting serum samples were analyzed for total and free IGF-I and -II, for IGFBP-1 to -4, as well as for IGFBP-3 proteolysis. Eleven weeks of physical training resulted in decreased levels of total IGF-I, free IGF-I, and IGFBP-4 in both the UT and WT groups. In the UT group, IGFBP-2 increased, IGFBP-3 decreased [from 4,255 ± 410 (baseline) to 3,896 ± 465 (SD) µg/l (week 4); P < 0.05], and IGFBP-3 proteolysis increased [from 28 ± 8% (baseline) to 37 ± 7% (week 4) and 39 ± 12% (week 11); P < 0.05], whereas no significant changes were found in the WT group. In conclusion, intense physical training results in a marked influence on the IGF system and its binding proteins with generally more extensive changes seen in the untrained individuals. Also, prolonged physical training resulted in increased IGFBP-3 proteolysis in previously untrained individuals only, indicating that intense physical training affects trained and untrained individuals differently.

insulin-like growth factor binding protein; proteolysis; human; exercise; fitness level


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

INSULIN-LIKE GROWTH FACTOR (IGF) I plays an important role in tissue anabolism by causing cell hypertrophy and hyperplasia in various cell types, including skeletal muscle myoblasts and tendon fibroblasts (1, 2, 11, 41). In addition, exercise training per se affects tissue anabolism (29, 30), and may provide general health benefits (6, 33), but exactly how exercise training and tissue anabolism interact and what mechanisms are responsible remain unclear. Although inconsistency exists (22), several cross-sectional studies have found significant positive correlations between fitness level and circulating IGF-I levels (9, 35). Such a correlation indicates that fitness and exercise in healthy, adolescent subjects is associated with increased activity of the IGF system, favoring an anabolic state. In contrast, prospective studies on exercise training and IGF-I have reported decreased circulating IGF-I levels (9, 10, 24, 38), mimicking responses typically found during energy-deficient and catabolic states (10, 24, 38, 39). However, these studies often had a rather short duration (3 days to 5 wk), and one paper hypothesized that the IGF-I adaptation to chronic exercise in fact consisted of a two-phase response, where an initial catabolic-type response was followed by a more chronic anabolic state after prolonged (>5-6 wk) training (10). That prolonged training does result in an increased activity of the IGF system is supported by findings from animal studies demonstrating that longer periods of training (4-9 wk) result in increased IGF-I gene expression in skeletal muscular tissue (44) and in increased circulating IGF-I levels (43). However, it is unclear to what extent the hypothesized two-phase response of IGF-I adaptations also holds true for humans during prolonged physical training.

The IGF-I action is believed in part to be mediated by circulating free IGF-I. During exercise and training, IGF binding protein (IGFBP)-3, through its proteolysis, represents a potent regulator of IGF-I bioactivity that can result in elevated concentrations of free IGF-I (37). Furthermore, increased IGFBP-3 proteolysis has been reported in one study that used an acute bout of exercise (37), whereas in a recent study on acute exercise no increase in IGFBP-3 proteolysis could be demonstrated (7). Independent of these diverse observations on responses to acute exercise, most previous studies have not addressed any potential role for IGFBP-3 proteolysis during a more chronic exposure to exercise and training. Nor has the influence of training on other IGFBPs and IGF-II been fully elucidated.

Accordingly, the aim of the present investigation was to study the regulatory changes in the circulating IGF system, including binding proteins and IGFBP-3 proteolysis, in response to prolonged physical training in young men. It was investigated whether the adaptation consisted of a two-phase response with an early adaptive effect (after 4 wk of training) and a more chronic adaptation (after 11 wk) as proposed by Eliakim et al. in 1998 (10). This was studied in both well-trained and untrained subjects to determine any potential influence of training status on responses. We hypothesized that highly standardized training would result in more extensive changes in the circulating IGF system in untrained subjects because of lower fitness level.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Subjects. Seven untrained and twelve well-trained healthy men, previously screened by the military medical board, were chosen from a larger group of conscripts who had volunteered for military duty at the Royal Danish Life Guard training camp. The Royal Danish Life Guard is considered one of the elite troop regiments within the Army, consisting of highly motivated soldiers. The training status of the subjects was determined on the basis of a fitness questionnaire that addressed the weekly amount of physical training during the last 12 mo before the study. The questionnaire also included a subjective assessment of current physical fitness level compared with that of other men at the same age, an assessment that has previously been validated by Washburn et al. (42). Each subject's individual training status was verified by a direct maximal oxygen consumption (VO2 max) determination. Subject characteristics are provided in Table 1. None of the subjects performed any training for 1 wk before the study, none was on any medication, and all were nonsmokers. Informed written consent was obtained from each subject before he was included in the study, which conformed to the Declaration of Helsinki and was approved by the Ethical Committee for medical research in Copenhagen (KF-01-118/99). Participation in the study was blinded toward the military that was responsible for the physical training.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Characteristics of the subjects

Study design. Fasting serum samples were collected before and after 4 and 11 wk of training. The 11 wk of standardized training consisted of 2-4 h daily training, categorized into four major groups (closed-order drill and marching, general conditioning, military-specific training, and open-order combat training), and each training session was conducted by a training officer. On average, the weekly training included 7 h of marching, 4 h of general conditioning (mostly running), and 9 h of military-specific training. Overall, the physical training primarily consisted of aerobic, lower extremity weight-bearing activities, but for 5-10% of the training time, intensity was aimed to be above the anaerobic threshold. The weekly amount of vigorous physical training was quantified by review of the recruit training schedules and by training reports from the training officers.

VO2 max. VO2 max was determined during the week before training, and it was evaluated during week 11 with an incremental VO2 max test on a motor-driven treadmill. The VO2 max protocol used was designed to have the subjects reach the VO2 max point within 3-7 min. After a 15-min warm-up, the subjects ran at an individually determined constant speed (13-16 km/h) throughout the test. After the first 2 min of the test, the treadmill was elevated 2° every 90-s until the subjects were unable to keep up with the pace. In the present study, all subjects completed the 2° elevation step (3.5 min) with an exercise range of 4.5-6.5 min, ensuring that VO2 max was reached. A criterion to establish that VO2 max was reached was that the respiratory quotient exceeded 1.10. Pulmonary oxygen uptake was measured with the Innovision Amis 2001 mixing chamber, on-line equipment (Odense, Denmark).

Blood sampling. All blood sampling was conducted after an overnight fast between 0630 and 0730 (baseline, week 4, and week 11). In addition, to avoid the effects of the previous training session, the subjects were not exposed to any strenuous exercise on the day before blood sampling, and each subject was ensured a minimum of 14 h of rest. The blood samples were drawn from an antecubital vein of the nondominant arm and were immediately iced and centrifuged at 5,000 rpm for 15 min (at 4°C). The serum was stored at -80°C until analysis.

Analytic methods. Serum total IGF-I and IGF-II were determined after acid-ethanol extraction by using noncompetitive time-resolved monoclonal immunofluorometric assays as previously described (16). Serum free IGF-I and IGF-II were determined by using ultrafiltration by centrifugation (19). Serum IGFBP-1 was determined by an enzyme-linked immunoassay (Medix Biochemica, Kauniainen, Finland). Serum IGFBP-3 was measured by immunoradiometric assay (IRMA) (Diagnostic System Laboratories, Webster, TX).

The within-assay coefficient of variation (CV) for total IGF-I, IGF-II, IGFBP-3, and IGFBP-1 averaged <5%. The within-assay CV for free IGF-I and free IGF-II averaged 18 and 12%, respectively. All samples were determined within the same assay.

Western ligand blotting (WLB), SDS-PAGE, and ligand blot analysis were performed in serum according to the method of Hossenlopp et al. (23) as previously described (12). Two microliters of serum were subjected to SDS-PAGE (10% polyacrylamide) under nonreducing conditions. Specificity of the IGFBP-2, IGFBP-3, and IGFBP-4 bands on WLBs was supported by competitive coincubation with unlabeled recombinant human IGF-I purchased from Bachem (Budendorf, Switzerland).

The 125I-labeled IGFBP-3 degradation assay was performed as previously described (7, 28). 125I-IGFBP-3 (30,000 counts/min) (Diagnostic System Laboratories) was incubated for 18 h at 37°C. Two microliters of serum from the subjects were subjected to SDS-PAGE as described above. On each gel, serum samples from a healthy nonpregnant subject and term-pregnant woman were used as internal controls. Gels were fixed in a solution of 7% acetic acid, dried, and autoradiographed. The degree of proteolysis was calculated as a ratio of the absorbency of fragmented 125I-IGFBP-3 to the sum of all 125I-IGFBP-3-related optical densities in that lane and was expressed as a percent. The between-assay CVs for the WLBs and the 125I-IGFBP-3 degradation assay were below 10%.

Autoradiograms of WLBs and the IGFBP-3 protease assay were quantified by densitometry with a Shimadzu CS-9001 PC dual-wavelength flying spot scanner (Shimadzu Europe, Duisburg, Germany). The relative density of the bands was measured as arbitrary absorbance units.

Statistical analysis. All data are presented as means ± SD. One-way ANOVA for repeated measures, approached by general linear modeling, was used to test for time effect during the training period (baseline, week 4, week 11). If the ANOVA test revealed significant changes, post hoc analyses by Tukey's multiple comparison were used to compare specific pairs of means. To examine whether differences existed between untrained and well-trained subjects, the independent-samples t-test was used (effect of training status) (SPSS Standard Version 11.0). Pearson's correlation was used to address the relationship between changes in free IGF-I and changes in IGFBP-1 and IGFBP-2. An alpha level of <0.05 (2 tailed) was accepted as significant.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The baseline characteristics of the subjects are presented in Table 1. Difference in training amounts, VO2 max, body weight, and body mass index were significant between well-trained and untrained subjects, whereas no significant differences were found between groups with regard to baseline IGF variables (Table 2, Figs. 1 and 2).

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Effects of 11 wk of standardized training on insulin-like growth factor variables (total IGF-II, free IGF-II, and IGFBP-4).



View larger version (10K):
[in this window]
[in a new window]
 
Fig. 1.   Serum total insulin-like growth factor I (IGF-I; A), free IGF-I (B), insulin-like growth factor binding protein (IGFBP)-1 (immunoradiometric assay; C), and IGFBP-2 [Western ligand blotting (WLB); D] in response to 11 wk of training (baseline, week 4, week 11) in 2 groups of young men with different initial training status. Values are means ± SD. Filled bars, well-trained individuals (n = 12); open bars, untrained individuals (n = 7). dagger  Significantly different from baseline value, P < 0.05.



View larger version (12K):
[in this window]
[in a new window]
 
Fig. 2.   IGFBP-3 (immunoradiometric assay; A), IGFBP-3 (WLB; B) and IGFBP-3 proteolysis (C) in response to 11 wk of training (baseline, week 4, week 11) in 2 groups of young men with different initial training status. Values are means ± SD. Filled bars, well-trained individuals (n = 12); open bars, untrained individuals (n = 7). dagger  Significantly different from baseline value, P < 0.05.

Effect of prolonged training. In response to the training period, untrained individuals significantly improved their VO2 max by 16 ± 4%, whereas VO2 max was unchanged in the well-trained subjects, which resulted in no significant group difference being evident at the end of week 11 (data not presented). The training intervention resulted in significant decreases in both total and free IGF-I in the untrained group from baseline to week 4 [by 14 ± 6% (total IGF-I) and 27 ± 19% (free IGF-I)] and from baseline to week 11 [by 15 ± 9% (total IGF-I) and 23 ± 18% (free IGF-I)] (Fig. 1). In the well-trained group, total IGF-I decreased by 9 ± 11% (P < 0.05) and free IGF-I decreased by 20 ± 24% (P < 0.05) from baseline to week 4 but had returned to baseline levels at week 11. IGFBP-2 increased significantly in the untrained group from baseline to weeks 4 and 11, whereas no significant changes from baseline were observed in well-trained group (Fig. 1). Overall (untrained + well trained), changes in free IGF-I were found to be inversely correlated with changes in IGFBP-1 and IGFBP-2 (-0.51 < r < -0.70, P < 0.05). IGFBP-3 (IRMA) and IGFBP-3 (WLB) transiently decreased in the untrained group from baseline to week 4 (P < 0.05) and returned to baseline levels at week 11, whereas no significant changes occurred in the well-trained group (Fig. 2). Compared with baseline, IGFBP-3 proteolysis increased in the untrained group (by 33 ± 26%; P < 0.05) after 4 wk and remained above baseline (by 36 ± 24%; P < 0.05) at 11 wk, whereas IGFBP-3 proteolysis in the well-trained group remained unchanged from baseline to week 11 (Fig. 2). Training caused IGFBP-4 to decrease over the 11-wk period in both the well-trained and untrained groups (Table 2).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

In the present study, total IGF-I decreased in both untrained and well-trained subjects after 4 wk of training, which is in contrast to results from a training study on collegiate swimmers that reported an increase in total and free IGF-I levels after 2 mo of training (26). A decrease in total IGF-I is, however, in accordance with other previously published endurance-type training studies (3, 9, 10, 24) and has recently been confirmed in a study on US Army Rangers performing 8 wk of physical training combined with sleep deprivation and relative reduced food intake (15). Findings from these relatively few studies investigating the response of IGF-I to chronic training would be in accordance with the view that both intensity and duration determine the resultant IGF-I levels.

One of the central findings in the present study is that the immonureactive IGFBP-3 levels decreased in untrained subjects from baseline to week 4 and returned to baseline in week 11, whereas no change was observed for well-trained individuals. Other training studies that used different training protocols found either unchanged (3, 10, 31) or increased IGFBP-3 levels (26, 27). To our knowledge, only one study has previously demonstrated that IGFBP-3 levels decreased with 5 wk of training; however, interestingly in that study, a decrease was also observed in the control group that did not perform any training (9). The transient IGFBP-3 decrease observed during prolonged training in the untrained group, but not in the well-trained group, indicates that either initial training status or the relative physiological stress applied during training affected the response. From the present data, it may be suggested that a threshold exists with regard to the relative physiological stress needed during training to result in proteolysis of IGFBP-3. Thus it may be speculated that the standardized training (baseline to week 11) was a sufficient stimulus to cause changes in IGFBP-3 in the untrained subjects, whereas prolonged periods of training with higher intensities would be needed to exceed the threshold in well-trained subjects. Unpublished results from our group indicate that if the intensity is sufficiently high, changes in IGFBP-3 and IGFBP-3 proteolysis do occur in both well-trained and untrained subjects; however, further studies are warranted to fully elucidate this hypothesis. Interestingly, a recent study conducted on soldiers during a 4-day sustained operation was able to confirm the present findings of a decrease in IGFBP-3 in response to intense physical loading (34).

The reduction in IGFBP-3 from baseline to week 4 in the untrained subjects was indicative of IGFBP-3 proteolysis. This was confirmed by the IGFBP-3 proteolysis assay, and it supports the notion that IGFBP-3 proteolysis can be increased in response to intense exercise and training. To our knowledge, there are no other studies investigating IGFBP-3 proteolysis during chronic training, whereas two studies have investigated the proteolytic response to acute exercise. Dall et al. (7) found albumin-adjusted IGFBP-3 proteolysis in elite rowers to be unaffected by 4× 5-min submaximal rowing exercise (55-85% VO2 max) followed by an 6- to 7-min all-out test (7). In contrast, Schwarz et al. (37) found a 10-min high-intensity cycle exercise in nonathletes to increase IGFBP-3 proteolytic activity by 44%. Schwarz et al. did not adjust for shifts in plasma volume, determined by a hematocrit (increase from 44 to 50%), which theoretically would account for at least 25% of the increased concentration in plasma-soluble variables (7). However, the increase in IGFBP-3 proteolytic activity with exercise in the study by Schwarz et al. cannot solely be accounted for by changes in hemoconcentration, and a marked difference in initial training status of the individuals could partly explain the differences in results between the two studies (7, 37).

Serum free IGF-I is markedly affected by changes in levels of IGFBP-1 and -2, which both correlate inversely with free IGF-I (17) (an inverse correlation that was also found in the present study). In addition, free IGF-I may be affected by changes in IGFBP-3 proteolysis, which is believed to represent a compensatory mechanism serving to increase free IGF-I by lowering IGFBP-3 ligand affinity and thereby modifying IGF-I bioavailability by releasing IGF-I from its 150-kDa complex, consisting of IGF-I, intact IGFBP-3, and an acid-labile subunit (36). It has been proposed that exercise-induced IGFBP-3 proteolysis would contribute significantly to the anabolic effects of exercise (36, 37); however, whereas there is little doubt that IGFBP-1 and -2 are potent regulators of free IGF-I levels (18), the physiological significance of IGFBP-3 proteolysis remains to be clarified. In the present study, the IGFBP-3 proteolysis observed in untrained subjects in week 4 and week 11 was not accompanied by any increase in free IGF-I. In contrast, free IGF-I was significantly decreased at all times (Fig. 1). Conditions other than physical training have been shown to be accompanied by a marked increase in IGFBP-3 proteolysis, for example, pregnancy. However, in pregnancy, although a high degree of proteolysis has occurred, still the concomitant increase in levels of free IGF-I is only about twofold (21). IGFBP-3 proteolysis is also observed in patients with chronic renal failure. However, in this condition, serum free IGF-I is markedly reduced, a finding that has been explained by the upregulated levels of IGFBP-1 and -2 (17). Thus it can be argued that changes in IGFBP-1 and -2 have relatively greater impact on levels of free IGF-I than IGFBP-3 proteolysis. This view is supported by the present study, where the upregulated levels of IGFBP-1 and -2 may explain the reduction in free IGF-I (7, 13, 19, 36), despite an increased IGFBP-3 proteolysis.

Total and free IGF-II remained unchanged in both untrained and well-trained subjects during the 11-wk training period, which is in contrast to findings of increased total IGF-II in a 3-mo training study on young subjects with cystic fibrosis (20). This increase in total IGF-II in patients with cystic fibrosis is likely to be due to low baseline levels. In healthy elderly marathon runners, measurements of total and free IGF-II were not different from sedentary age-matched controls, indicating that there is no effect of prolonged training on IGF-II in elderly subjects (8). IGF-II may play an important role in stimulation of bone growth and development (25), but the physiological response of IGF-II to prolonged training is very sparsely reported and the biological importance has yet to be determined (37).

After 4 wk of training, IGFBP-4 had decreased in both well-trained and untrained subjects and remained lower after 11 wk also. IGFBP-4 has consistently been shown to inhibit IGF-I action but has also been shown to be able to undergo proteolytic cleavage, which has been speculated to increase the action of IGF-I (4, 5). Previous studies have shown that IGFBP-4 is degraded only in the presence of exogenous IGFs, but Fowlkes et al. (14) have shown that, in vitro, IGFBP-4 can be degraded in the absence of IGFs, an effect that was almost entirely inhibited by the addition of IGFBP-3 to the medium. Fowlkes et al. therefore speculated that IGFBP-3 has the potential to regulate IGFBP-4 proteolysis in vivo. The interaction between IGFs and IGFBP-3 and -4 is undoubtedly very complex, and even though the probable role is to regulate the IGF interaction at the cell surface, the in vivo physiological role has not yet been elucidated. In a recent paper by van Doorn et al. (40), the clinical relevance of IGFBP-4 in various pathological conditions was examined and the conclusion was that IGFBP-4 might be of minor clinical importance in patients with hyperthyroidism, hypothyroidism, growth hormone deficiency, acromegaly, and chronic renal failure. However, during intense physical training that seems to reflect a systemic catabolic state, proteolysis of IGFBP-4 could have an important compensatory local effect. Therefore, the reduction in IGFBP-4, found in the present study, could have the physiological role of counteracting the concomitant decrease in free and total IGF-I that was seen after 4 wk of training and thereby reduce the catabolic-like early effect of training and maybe even increase a local anabolic effect.

It could be argued that the training regimen used in this study would lead to a general state of tissue catabolism. However, interestingly, it was shown in the same subjects that both degradation and synthesis of collagen type I were increased around the Achilles tendon after 4 wk of training followed by a net synthesis after 11 wk of training (29). This evidently does not allow for any quantitative statements regarding whole body anabolism or catabolism, but at least it indicates that enzymatic degradation of connective tissue primarily is dominant in the early training phase, indicative of a more catabolic state than later during the training period. Such a phenomenon may have been more pronounced in untrained vs. trained subjects, and it could support the view of a two-phased response in the IGF system with regard to prolonged training (7). Finally, it cannot be excluded that local tissue IGF-I levels were increased despite reduced circulating levels, that paracrine or autocrine growth promotion exists, or that increased numbers of cell-surface IGF receptors (or altered sensitivity) could be responsible for more differentiated local anabolic responses (13, 32, 36).

In conclusion, the results from the present study indicate that 11 wk of physical training affect serum levels of total and free IGF-I, IGFBP-2, and IGFBP-3 and affect IGFBP-3 proteolysis differently in untrained and well-trained subjects, with more extensive changes seen in the untrained subjects. Furthermore, the training-induced reduction in IGFBP-3 and concomitant increase in IGFBP-3 proteolysis in previously untrained individuals suggest the existence of a threshold for relative physiological stress to be exceeded in order for IGFBP-3 proteolysis to occur.


    ACKNOWLEDGEMENTS

We thank Annie Høj, Karen Mathiassen, and Kirsten Nyborg for excellent technical assistance.


    FOOTNOTES

This study was supported by the Team Denmark Research Council, the Danish Sports Science Foundation, the Novo Nordisk Foundation, the Danish Medical Research Council (980236, 9700592), the Eva and Henry Frænkels Memorial Foundation, Copenhagen University Hospital Research Foundation, the Aarhus University-Novo Nordisk Center for Research in Growth and Regeneration (9600822), and the Danish National Research Foundation (504-14).

Address for reprint requests and other correspondence: L. Rosendal, National Institute of Occupational Health, Lersø Parkallé 105, DK-2100 Copenhagen, Denmark (E-mail: LRL{at}ami.dk).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

July 12, 2002;10.1152/japplphysiol.00145.2002

Received 25 February 2002; accepted in final form 5 July 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Abrahamsson, SO. Similar effects of recombinant human insulin-like growth factor-I and II on cellular activities in flexor tendons of young rabbits: experimental studies in vitro. J Orthop Res 15: 256-262, 1997[ISI][Medline].

2.   Banes, AJ, Tsuzaki M, Hu P, Brigman B, Brown T, Almekinders L, Lawrence WT, and Fischer T. PDGF-BB, IGF-I and mechanical load stimulate DNA synthesis in avian tendon fibroblasts in vitro. J Biomech 28: 1505-1513, 1995[ISI][Medline].

3.   Chicharro, JL, Lopez-Calderon A, Hoyos J, Martin-Velasco AI, Villa G, Villanua MA, and Lucia A. Effects of an endurance cycling competition on resting serum insulin-like growth factor I (IGF-I) and its binding proteins IGFBP-1 and IGFBP-3. Br J Sports Med 35: 303-307, 2001[Abstract/Free Full Text].

4.   Clemmons, DR. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8: 45-62, 1997[Medline].

5.   Conover, CA. Regulation and physiological role of insulin-like growth factor binding proteins. Endocr J 43, Suppl: S43-S48, 1996.

6.   Cooper, DM. Evidence for and mechanisms of exercise modulation of growth---an overview. Med Sci Sports Exerc 26: 733-740, 1994[ISI][Medline].

7.   Dall, R, Lange KH, Kjaer M, Jorgensen JO, Christiansen JS, Orskov H, and Flyvbjerg A. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes. J Clin Endocrinol Metab 86: 669-674, 2001[Abstract/Free Full Text].

8.   Deuschle, M, Blum WF, Frystyk J, Orskov H, Schweiger U, Weber B, Korner A, Gotthardt U, Schmider J, Standhardt H, and Heuser I. Endurance training and its effect upon the activity of the GH-IGFs system in the elderly. Int J Sports Med 19: 250-254, 1998[ISI][Medline].

9.   Eliakim, A, Brasel JA, Mohan S, Barstow TJ, Berman N, and Cooper DM. Physical fitness, endurance training, and the growth hormone-insulin-like growth factor I system in adolescent females. J Clin Endocrinol Metab 81: 3986-3992, 1996[Abstract/Free Full Text].

10.   Eliakim, A, Brasel JA, Mohan S, Wong WL, and Cooper DM. Increased physical activity and the growth hormone-IGF-I axis in adolescent males. Am J Physiol Regul Integr Comp Physiol 275: R308-R314, 1998[Abstract/Free Full Text].

11.   Florini, JR, Ewton DZ, Falen SL, and Van Wyk JJ. Biphasic concentration dependency of stimulation of myoblast differentiation by somatomedins. Am J Physiol Cell Physiol 250: C771-C778, 1986[Abstract/Free Full Text].

12.   Flyvbjerg, A, Kessler U, Dorka B, Funk B, Ørskov H, and Kiess W. Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia 35: 589-593, 1992[ISI][Medline].

13.   Fowlkes, JL. Insulinlike growth factor-binding protein proteolysis. An emerging paradigm in insulinlike growth factor physiology. Trends Endocrinol Metab 8: 299-306, 1997[Medline].

14.   Fowlkes, JL, Serra DM, Rosenberg CK, and Thrailkill KM. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis. J Biol Chem 270: 27481-27488, 1995[Abstract/Free Full Text].

15.   Friedl, KE, Moore RJ, Hoyt RW, Marchitelli LJ, Martinez-Lopez LE, and Askew EW. Endocrine markers of semistarvation in healthy lean men in a multistressor environment. J Appl Physiol 88: 1820-1830, 2000[Abstract/Free Full Text].

16.   Frystyk, J, Dinesen B, and Ørskov H. Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. Growth Regul 5: 169-176, 1995[ISI][Medline].

17.   Frystyk, J, Ivarsen P, Skjaerbaek C, Flyvbjerg A, Pedersen EB, and Ørskov H. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney Int 56: 2076-2084, 1999[Medline].

18.   Frystyk, J, Ivarsen P, Stoving RK, Dall R, Bek T, Hagen C, and Orskov H. Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay. Growth Horm IGF Res 11: 117-127, 2001[ISI][Medline].

19.   Frystyk, J, Skjaerbaek C, Dinesen B, and Ørskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett 348: 185-191, 1994[ISI][Medline].

20.   Gulmans, V, van der Laag J, Wattimena D, van Doom J, Oostveen D, Berger R, and de Meer K. Insulin-like growth factors and leucine kinetics during exercise training in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 32: 76-81, 2001[Medline].

21.   Hasegawa, T, Hasegawa Y, Takada M, and Tsuchiya Y. The free form of insulin-like growth factor I increases in circulation during normal human pregnancy. J Clin Endocrinol Metab 80: 3284-3286, 1995[Abstract].

22.   Haydar, ZR, Blackman MR, Tobin JD, Wright JG, and Fleg JL. The relationship between aerobic exercise capacity and circulating IGF-1 levels in healthy men and women. J Am Geriatr Soc 48: 139-145, 2000[ISI][Medline].

23.   Hossenlopp, P, Seurin D, Segovia-Quinson B, Hardouin S, and Binoux M. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154: 138-143, 1986[ISI][Medline].

24.   Jahreis, G, Kauf E, Frohner G, and Schmidt HE. Influence of intensive exercise on insulin-like growth factor I, thyroid and steroid hormones in female gymnasts. Growth Regul 1: 95-99, 1991[ISI][Medline].

25.   Jia, D, and Heersche JN. Insulin-like growth factor-1 and -2 stimulate osteoprogenitor proliferation and differentiation and adipocyte formation in cell populations derived from adult rat bone. Bone 27: 785-794, 2000[Medline].

26.   Koziris, LP, Hickson RC, Chatterton RT, Jr, Groseth RT, Christie JM, Goldflies DG, and Unterman TG. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. J Appl Physiol 86: 1436-1442, 1999[Abstract/Free Full Text].

27.   Kraemer, WJ, Hakkinen K, Newton RU, Nindl BC, Volek JS, McCormick M, Gotshalk LA, Gordon SE, Fleck SJ, Campbell WW, Putukian M, and Evans WJ. Effects of heavy-resistance training on hormonal response patterns in younger vs. older men. J Appl Physiol 87: 982-992, 1999[Abstract/Free Full Text].

28.   Lamson, G, Giudice LC, and Rosenfeld RG. A simple assay for proteolysis of IGFBP-3. J Clin Endocrinol Metab 72: 1391-1393, 1991[Abstract].

29.   Langberg, H, Rosendal L, and Kjaer M. Training-induced changes in peritendinous type I collagen turnover determined by microdialysis in humans. J Physiol 534: 297-302, 2001[Abstract/Free Full Text].

30.   Leveritt, M, Abernethy PJ, Barry BK, and Logan PA. Concurrent strength and endurance training. A review. Sports Med 28: 413-427, 1999[Medline].

31.   Maddalozzo, GF, and Snow CM. High intensity resistance training: effects on bone in older men and women. Calcif Tissue Int 66: 399-404, 2000[ISI][Medline].

32.   McCusker, RH. Controlling insulin-like growth factor activity and the modulation of insulin-like growth factor binding protein and receptor binding. J Dairy Sci 81: 1790-1800, 1998[Abstract].

33.   National Institutes of Health. Healthy people 2000: national health promotion and disease prevention objectives. US Public Health Service. J Allied Health 19: 297-311, 1990[Medline].

34.   Nindl, BC, Montain JW, Castellani MD, Smith WTJ, and Stulz DA. Military operational stress alters serum concentrations of insulin-like growth factor-I binding proteins (Abstract). FASEB J 1: A757, 2001.

35.   Poehlman, ET, and Copeland KC. Influence of physical activity on insulin-like growth factor-I in healthy younger and older men. J Clin Endocrinol Metab 71: 1468-1473, 1990[Abstract].

36.   Rajaram, S, Baylink DJ, and Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 18: 801-831, 1997[Abstract/Free Full Text].

37.   Schwarz, AJ, Brasel JA, Hintz RL, Mohan S, and Cooper DM. Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab 81: 3492-3497, 1996[Abstract].

38.   Smith, AT, Clemmons DR, Underwood LE, Ben Ezra V, and McMurray R. The effect of exercise on plasma somatomedin-C/insulinlike growth factor I concentrations. Metabolism 36: 533-537, 1987[ISI][Medline].

39.   Smith, WJ, Underwood LE, and Clemmons DR. Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab 80: 443-449, 1995[Abstract].

40.   Van Doorn, J, Cornelissen AJ, and Buul-Offers SC. Plasma levels of insulin-like growth factor binding protein-4 (IGFBP-4) under normal and pathological conditions. Clin Endocrinol (Oxf) 54: 655-664, 2001[Medline].

41.   Vandenburgh, HH, Karlisch P, Shansky J, and Feldstein R. Insulin and IGF-I induce pronounced hypertrophy of skeletal myofibers in tissue culture. Am J Physiol Cell Physiol 260: C475-C484, 1991[Abstract/Free Full Text].

42.   Washburn, RA, Adams LL, and Haile GT. Physical activity assessment for epidemiologic research: the utility of two simplified approaches. Prev Med 16: 636-646, 1987[ISI][Medline].

43.   Yeh, JK, Aloia JF, Chen M, Ling N, Koo HC, and Millard WJ. Effect of growth hormone administration and treadmill exercise on serum and skeletal IGF-I in rats. Am J Physiol Endocrinol Metab 266: E129-E135, 1994[Abstract/Free Full Text].

44.   Zanconato, S, Moromisato DY, Moromisato MY, Woods J, Brasel JA, Leroith D, Roberts CT, Jr, and Cooper DM. Effect of training and growth hormone suppression on insulin-like growth factor I mRNA in young rats. J Appl Physiol 76: 2204-2209, 1994[Abstract/Free Full Text].


J APPL PHYSIOL 93(5):1669-1675
8750-7587/02 $5.00 Copyright © 2002 the American Physiological Society



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
K. R. Rarick, M. A. Pikosky, A. Grediagin, T. J. Smith, E. L. Glickman, J. A. Alemany, J. S. Staab, A. J. Young, and B. C. Nindl
Energy flux, more so than energy balance, protein intake, or fitness level, influences insulin-like growth factor-I system responses during 7 days of increased physical activity
J Appl Physiol, November 1, 2007; 103(5): 1613 - 1621.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. L. Olesen, K. M. Heinemeier, C. Gemmer, M. Kjaer, A. Flyvbjerg, and H. Langberg
Exercise-dependent IGF-I, IGFBPs, and type I collagen changes in human peritendinous connective tissue determined by microdialysis
J Appl Physiol, January 1, 2007; 102(1): 214 - 220.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
M Elloumi, N El Elj, M Zaouali, F Maso, E Filaire, Z Tabka, and G Lac
IGFBP-3, a sensitive marker of physical training and overtraining
Br. J. Sports Med., September 1, 2005; 39(9): 604 - 610.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. L. Ballard, J. A Clapper, B. L Specker, T. L Binkley, and M. D Vukovich
Effect of protein supplementation during a 6-mo strength and conditioning program on insulin-like growth factor I and markers of bone turnover in young adults
Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1442 - 1448.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. KJAeR
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
Physiol Rev, April 1, 2004; 84(2): 649 - 698.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. Nemet, P. H. Connolly, A. M. Pontello-Pescatello, C. Rose-Gottron, J. K. Larson, P. Galassetti, and D. M. Cooper
Negative energy balance plays a major role in the IGF-I response to exercise training
J Appl Physiol, January 1, 2004; 96(1): 276 - 282.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. C. Nindl, J. W. Castellani, A. J. Young, J. F. Patton, M. J. Khosravi, A. Diamandi, and S. J. Montain
Differential responses of IGF-I molecular complexes to military operational field training
J Appl Physiol, September 1, 2003; 95(3): 1083 - 1089.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
93/5/1669    most recent
00145.2002v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosendal, L.
Right arrow Articles by Kjær, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosendal, L.
Right arrow Articles by Kjær, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online